Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

1,200 babies join study to map early brain development

NCT ID NCT07418528

Knowledge-focused Sponsor: Bartosz M. Radtke Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This observational study aims to understand how infants and toddlers develop thinking, language, movement, and social skills in the first few years of life. Researchers will assess 1,200 children aged 16 days to 42 months using standardized tests and parent questionnaires. The goal is to identify typical developmental patterns and early signs of potential difficulties, which could help improve early diagnosis and support for children at risk.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could improve early detection of developmental delays in young children, leading to better support and interventions.
What could go wrong
This is an observational study, not a treatment trial. It will not directly benefit participants, and findings may not apply to all children or lead to immediate changes in care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 1,200 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2025

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Infants and young children aged 16 days to 42 months, including children with typical development and children with increased developmental risk.

Ages

16 days to 42 months

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Infants and young children aged from 16 days to 42 months at the time of assessment. * Participation of a parent or legal guardian able to provide informed consent. * Child's ability to participate in a standardized developmental assessment appropriate for age and developmental level. * Availability of basic medical and perinatal information provided by parents or caregivers. * Assignment to one of the predefined study cohorts based on medical history and developmental status: children from the general population (control group), children with developmental delay, children with confirmed genetic conditions, children born preterm between 33 and 37 weeks of gestation, children born before 33 weeks of gestation, children with a diagnosis of cerebral palsy. Exclusion Criteria: * Severe acute medical condition at the time of assessment preventing participation in the psychological evaluation. * Uncorrected severe sensory impairments (e.g., profound visual or hearing impairment) that preclude valid administration or interpretation of the developmental assessment. * Medical instability or conditions requiring immediate intensive medical care. * Lack of informed consent from a parent or legal guardian. * Inability of the parent or caregiver to provide reliable information required for questionnaire-based assessment.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cerebral palsy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cerebral palsy hereditary disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Child development Early childhood development Infant development

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Laboratory of Psychological and Educational Tests

    RECRUITING

    Gdansk, Pomeranian Voivodeship, 80-239, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.